VTX:ROG - Roche Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
CHF 219.60 -1.20 (-0.54 %)
(As of 05/24/2018 04:00 PM ET)
Previous CloseCHF 229
Today's RangeCHF 219.15 - CHF 220.40
52-Week RangeCHF 214.30 - CHF 273
Volume3.74 million shs
Average Volume2.09 million shs
Market Capitalization$191.16 billion
P/E RatioN/A
Dividend Yield3.78%
BetaN/A

About Roche (VTX:ROG)

Roche logoRogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense. Its Elastomeric Material Solutions segment provides elastomeric material solutions for critical cushioning, sealing, impact protection, and vibration management applications, including general industrial, portable electronics, consumer goods, automotive, mass transportation, construction, and printing applications. The company's Power Electronics Solutions segment offers ceramic substrate materials for power module applications, laminated bus bars for power inverter and high power interconnect applications, and micro-channel coolers. Its Other segment provides elastomeric components for applications in ground transportation, office equipment, consumer, and other markets; elastomer floats for level sensing in fuel tanks, motors, and storage tanks; and inverters for portable communications and automotive markets. The company also manufactures and sells polytetrafluoroethylene, ultra-high molecular weight polyethylene films, pressure sensitive tapes, and specialty products for the industrial, aerospace, automotive, and electronics markets. Rogers Corporation was founded in 1832 and is headquartered in Chandler, Arizona.

Receive ROG News and Ratings via Email

Sign-up to receive the latest news and ratings for ROG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diversified Electronics
Sub-IndustryN/A
SectorComputer and Technology
SymbolVTX:ROG
CUSIPN/A
Phone+41-9-732354295

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins12.05%
Return on Equity25.56%
Return on Assets8.72%

Miscellaneous

EmployeesN/A
Outstanding Shares693,300,000

Roche (VTX:ROG) Frequently Asked Questions

What is Roche's stock symbol?

Roche trades on the VTX under the ticker symbol "ROG."

What price target have analysts set for ROG?

20 equities research analysts have issued 12-month target prices for Roche's shares. Their predictions range from CHF 195 to CHF 300. On average, they expect Roche's stock price to reach CHF 254.16 in the next year. View Analyst Ratings for Roche.

Who are some of Roche's key competitors?

Who are Roche's key executives?

Roche's management team includes the folowing people:
  • Mr. Bruce D. Hoechner, Pres, CEO & Director (Age 58)
  • Ms. Janice E. Stipp, Sr. VP of Fin., CFO, & Treasurer (Age 58)
  • Mr. Robert C. Daigle, Sr. VP & CTO (Age 55)
  • Mr. Jay B. Knoll, Sr. VP of Corp. Devel., Gen. Counsel & Corp. Sec. (Age 55)
  • Ms. Helen Zhang, Sr. VP, GM of Power Electronics Solutions & Pres of Rogers Asia (Age 54)

Has Roche been receiving favorable news coverage?

News stories about ROG stock have been trending somewhat positive recently, Accern Sentiment reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Roche earned a news impact score of 0.07 on Accern's scale. They also assigned news articles about the healthcare company an impact score of 45.41 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

What is Roche's stock price today?

One share of ROG stock can currently be purchased for approximately CHF 219.60.

How big of a company is Roche?

Roche has a market capitalization of $191.16 billion.

How can I contact Roche?

Roche's mailing address is Grenzacherstr. 124, BASEL, 4058, Switzerland. The healthcare company can be reached via phone at +41-9-732354295.


MarketBeat Community Rating for Roche (ROG)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  328 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  459
MarketBeat's community ratings are surveys of what our community members think about Roche and other stocks. Vote "Outperform" if you believe ROG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ROG will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Roche (VTX:ROG) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
20 Wall Street analysts have issued ratings and price targets for Roche in the last 12 months. Their average twelve-month price target is CHF 254.16The high price target for ROG is CHF 300 and the low price target for ROG is CHF 195. There are currently 4 sell ratings, 7 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.302.352.29
Ratings Breakdown: 4 Sell Rating(s)
7 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
7 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: CHF 254.16CHF 254.89CHF 259.37CHF 265.24

Roche (VTX:ROG) Consensus Price Target History

Price Target History for Roche (VTX:ROG)

Roche (VTX:ROG) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/23/2018BarclaysSet Price TargetBuyCHF 295View Rating Details
5/22/2018Deutsche BankReiterated RatingNeutralView Rating Details
5/22/2018CitigroupSet Price TargetNeutralCHF 240View Rating Details
5/22/2018Jefferies GroupSet Price TargetBuyCHF 290View Rating Details
5/18/2018UBSSet Price TargetNeutralCHF 237View Rating Details
5/17/2018JPMorgan Chase & Co.Set Price TargetBuyCHF 300View Rating Details
5/14/2018Kepler Capital MarketsSet Price TargetNeutralCHF 238View Rating Details
5/10/2018Sanford C. BernsteinSet Price TargetNeutralCHF 244View Rating Details
4/27/2018Credit Suisse GroupSet Price TargetNeutralCHF 240View Rating Details
4/26/2018DZ BankReiterated RatingBuyView Rating Details
4/26/2018Berenberg BankSet Price TargetNeutralCHF 260View Rating Details
4/26/2018Goldman Sachs GroupSet Price TargetBuyCHF 300View Rating Details
4/17/2018Morgan StanleySet Price TargetSellCHF 230View Rating Details
3/14/2018Societe GeneraleSet Price TargetSellCHF 195View Rating Details
1/2/2018Nord/LBReiterated RatingBuyView Rating Details
12/6/2017Bank of AmericaSet Price TargetBuyCHF 275View Rating Details
11/22/2017Liberum CapitalSet Price TargetBuyCHF 279View Rating Details
11/21/2017Baader BankSet Price TargetBuyCHF 256View Rating Details
11/21/2017HSBCSet Price TargetSellCHF 205View Rating Details
9/25/2017BNP ParibasSet Price TargetSellCHF 235View Rating Details
(Data available from 5/24/2016 forward)

Earnings

Dividends

Roche (VTX:ROG) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Roche (VTX ROG) Insider Trading and Institutional Ownership History

Insider Trading History for Roche (VTX:ROG)

Roche (VTX ROG) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Roche (VTX ROG) News Headlines

Source:
DateHeadline
Barclays Analysts Give Roche (ROG) a CHF 295 Price TargetBarclays Analysts Give Roche (ROG) a CHF 295 Price Target
www.americanbankingnews.com - May 23 at 8:22 AM
Roche (ROG) Earns "Neutral" Rating from Deutsche BankRoche (ROG) Earns "Neutral" Rating from Deutsche Bank
www.americanbankingnews.com - May 22 at 12:31 PM
Jefferies Group Reiterates CHF 290 Price Target for Roche (ROG)Jefferies Group Reiterates CHF 290 Price Target for Roche (ROG)
www.americanbankingnews.com - May 22 at 9:47 AM
Citigroup Reiterates "CHF 240" Price Target for Roche (ROG)Citigroup Reiterates "CHF 240" Price Target for Roche (ROG)
www.americanbankingnews.com - May 22 at 9:47 AM
Roche drug dramatically reduces bleeding in key hemophilia testsRoche drug dramatically reduces bleeding in key hemophilia tests
www.cnbc.com - May 21 at 8:13 AM
Market Trends Toward New Normal in Colony NorthStar, Badger Meter, Dun & Bradstreet, Ryman Hospitality Properties, Rogers, and Pool — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Colony NorthStar, Badger Meter, Dun & Bradstreet, Ryman Hospitality Properties, Rogers, and Pool — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - May 21 at 8:13 AM
UBS Reiterates CHF 237 Price Target for Roche (ROG)UBS Reiterates CHF 237 Price Target for Roche (ROG)
www.americanbankingnews.com - May 18 at 4:13 PM
JPMorgan Chase Reiterates CHF 300 Price Target for Roche (ROG)JPMorgan Chase Reiterates CHF 300 Price Target for Roche (ROG)
www.americanbankingnews.com - May 17 at 11:35 AM
Roche immunotherapy combination increases lung cancer survival - studyRoche immunotherapy combination increases lung cancer survival - study
www.reuters.com - May 17 at 8:19 AM
Roches Actemra gets FDA OK for pediatric useRoche's Actemra gets FDA OK for pediatric use
www.marketwatch.com - May 15 at 8:23 AM
Jefferies Group Analysts Give Roche (ROG) a CHF 290 Price TargetJefferies Group Analysts Give Roche (ROG) a CHF 290 Price Target
www.americanbankingnews.com - May 14 at 10:39 AM
Kepler Capital Markets Analysts Give Roche (ROG) a CHF 238 Price TargetKepler Capital Markets Analysts Give Roche (ROG) a CHF 238 Price Target
www.americanbankingnews.com - May 14 at 10:39 AM
FDA Okays Additional Claim For Roche Cobas Zika TestFDA Okays Additional Claim For Roche Cobas Zika Test
www.nasdaq.com - May 14 at 8:23 AM
FDA approves additional claim for Roche cobas Zika testFDA approves additional claim for Roche cobas Zika test
www.prnewswire.com - May 14 at 8:23 AM
Roche (ROG) Given a CHF 295 Price Target at BarclaysRoche (ROG) Given a CHF 295 Price Target at Barclays
www.americanbankingnews.com - May 11 at 6:29 PM
Roche (ROG) PT Set at CHF 300 by JPMorgan ChaseRoche (ROG) PT Set at CHF 300 by JPMorgan Chase
www.americanbankingnews.com - May 11 at 6:29 PM
Sanford C. Bernstein Analysts Give Roche (ROG) a CHF 244 Price TargetSanford C. Bernstein Analysts Give Roche (ROG) a CHF 244 Price Target
www.americanbankingnews.com - May 10 at 6:33 PM
Roche cancer drug study misses primary endpointRoche cancer drug study misses primary endpoint
www.marketwatch.com - May 10 at 8:20 AM
Roche lung cancer drug gets FDA priority reviewRoche lung cancer drug gets FDA priority review
www.marketwatch.com - May 7 at 8:17 AM
Roche Holding AG (ROG) Receives Average Rating of "Hold" from AnalystsRoche Holding AG (ROG) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 7 at 3:30 AM
Claudia Gelfond, Cameron RocheClaudia Gelfond, Cameron Roche
www.nytimes.com - May 6 at 8:21 AM
Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-MyersFlatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers
www.forbes.com - May 2 at 8:19 AM
Roche Diabetes Care Rallies People Across the Country to Join the #BuckOffDiabetes CampaignRoche Diabetes Care Rallies People Across the Country to Join the #BuckOffDiabetes Campaign
www.prnewswire.com - May 1 at 8:22 AM
Edited Transcript of ROG earnings conference call or presentation 26-Apr-18 9:00pm GMTEdited Transcript of ROG earnings conference call or presentation 26-Apr-18 9:00pm GMT
finance.yahoo.com - April 28 at 8:26 AM
Roche Holdings (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call TranscriptRoche Holding's (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 27 at 8:27 AM
Credit Suisse Group Analysts Give Roche (ROG) a CHF 240 Price TargetCredit Suisse Group Analysts Give Roche (ROG) a CHF 240 Price Target
www.americanbankingnews.com - April 27 at 6:26 AM
Roches (ROG) Buy Rating Reiterated at DZ BankRoche's (ROG) Buy Rating Reiterated at DZ Bank
www.americanbankingnews.com - April 26 at 12:27 PM
Roche (ROG) Given a CHF 260 Price Target at Berenberg BankRoche (ROG) Given a CHF 260 Price Target at Berenberg Bank
www.americanbankingnews.com - April 26 at 12:27 PM
Roche (ROG) PT Set at CHF 236 by Kepler Capital MarketsRoche (ROG) PT Set at CHF 236 by Kepler Capital Markets
www.americanbankingnews.com - April 26 at 12:27 PM
Goldman Sachs Analysts Give Roche (ROG) a CHF 300 Price TargetGoldman Sachs Analysts Give Roche (ROG) a CHF 300 Price Target
www.americanbankingnews.com - April 26 at 10:33 AM
BRIEF-Roche Holding AG CEO Says Very Confident We Can Grow In Spite Of The Entry Of BiosimilarsBRIEF-Roche Holding AG CEO Says Very Confident We Can Grow In Spite Of The Entry Of Biosimilars
www.reuters.com - April 26 at 8:14 AM
Roche CEO Very Confident on European Sales GrowthRoche CEO 'Very Confident' on European Sales Growth
www.bloomberg.com - April 26 at 8:14 AM
Roche Lifts Forecast as Bet Outside Cancer Starts to Pay OffRoche Lifts Forecast as Bet Outside Cancer Starts to Pay Off
www.bloomberg.com - April 26 at 8:14 AM
Roche upgrades growth forecast after new drugs boost salesRoche upgrades growth forecast after new drugs boost sales
www.ft.com - April 26 at 8:14 AM
Ex-Roche scientist Reed to head Sanofi R&D as Zerhouni retiresEx-Roche scientist Reed to head Sanofi R&D as Zerhouni retires
www.reuters.com - April 24 at 8:17 AM
FDA declines to approve Pfizers biosimilar to Roches cancer drugFDA declines to approve Pfizer's biosimilar to Roche's cancer drug
www.reuters.com - April 23 at 8:13 AM
Roche (ROG) Given "Buy" Rating at JPMorgan ChaseRoche (ROG) Given "Buy" Rating at JPMorgan Chase
www.americanbankingnews.com - April 23 at 7:08 AM
Roche (ROG) PT Set at CHF 250 by BNP ParibasRoche (ROG) PT Set at CHF 250 by BNP Paribas
www.americanbankingnews.com - April 20 at 8:01 PM
JPMorgan Chase Reiterates "Buy" Rating for Roche (ROG)JPMorgan Chase Reiterates "Buy" Rating for Roche (ROG)
www.americanbankingnews.com - April 20 at 4:17 PM
Roche (ROG) PT Set at CHF 335 by Goldman SachsRoche (ROG) PT Set at CHF 335 by Goldman Sachs
www.americanbankingnews.com - April 20 at 4:16 PM
Roche (ROG) Given a CHF 273 Price Target by Deutsche Bank AnalystsRoche (ROG) Given a CHF 273 Price Target by Deutsche Bank Analysts
www.americanbankingnews.com - April 20 at 3:36 PM
UBS Reiterates "CHF 260" Price Target for Roche (ROG)UBS Reiterates "CHF 260" Price Target for Roche (ROG)
www.americanbankingnews.com - April 19 at 8:00 PM
Roche (ROG) Given a CHF 235 Price Target at Kepler Capital MarketsRoche (ROG) Given a CHF 235 Price Target at Kepler Capital Markets
www.americanbankingnews.com - April 19 at 4:34 PM
Roche (ROG) Given a CHF 290 Price Target by Morgan Stanley AnalystsRoche (ROG) Given a CHF 290 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - April 19 at 2:58 PM
Roche (ROG) Given a CHF 280 Price Target at Berenberg BankRoche (ROG) Given a CHF 280 Price Target at Berenberg Bank
www.americanbankingnews.com - April 19 at 2:58 PM
BRIEF-Roche Expands Indication For Cobas EGFR Mutation Test V2 As Companion Diagnostic With TagrissoBRIEF-Roche Expands Indication For Cobas EGFR Mutation Test V2 As Companion Diagnostic With Tagrisso
www.reuters.com - April 19 at 8:13 AM
Roche (ROG) Rating Reiterated by JPMorgan ChaseRoche (ROG) Rating Reiterated by JPMorgan Chase
www.americanbankingnews.com - April 18 at 12:16 PM
Roche (ROG) Given a CHF 300 Price Target by Goldman Sachs AnalystsRoche (ROG) Given a CHF 300 Price Target by Goldman Sachs Analysts
www.americanbankingnews.com - April 18 at 10:15 AM
Roche (ROG) PT Set at CHF 240 by Credit Suisse GroupRoche (ROG) PT Set at CHF 240 by Credit Suisse Group
www.americanbankingnews.com - April 18 at 8:14 AM
4000000 Reasons to Back China Biotech4000000 Reasons to Back China Biotech
www.bloomberg.com - April 18 at 8:13 AM

SEC Filings

Roche (VTX:ROG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Roche (VTX ROG) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.